EUS-guided Transenteric Drainage With a Novel Lumen-apposing Metal Stent

Inclusion Criteria: Patient must meet all of the following inclusion criteria to be eligible for enrollment into the study. * Pancreatobiliary diseases that are eligible for EUS-guided transenteric drainage * The patient who aged from 20 to 80 years. Legally acceptable representative must be capable of giving written informed consent prior to participation in this study * Target lesion that is accessible through the transenteric approach * The woman of child-bearing age must be negative from the pregnancy test in order to participate in this study * The patient who is willing and able to comply with the scheduled visits, treatment plan, laboratory tests, and other study procedures * The patients should not have any unacceptable conditions (e.g., physiological, familyism, social, geographical) for medical follow-up and adaptation of the study. Exclusion Criteria: Patient presenting with any of the following will not be included in the study. * Inaccessible to EUS-guided approach * Bleeding tendency: International normalized ratio (INR) of prothrombin time \< 1.5 or platelet conunt \< 60,000/mm3 * Patients with Disseminated Intravascular Coagulation syndrome(DIC) * Patients who have been taking medicines that can cause hemorrhage (e.g., Aspirin, Wafarin etc.) * Patients with other serious disease or medical condition * Patients with past medical history of significant neurologic or Psychiatric disorders such as dementia or seizure * Unstable heart disease despite of treatment, recent myocardial infarction within 6 month (Even though MI was diagnosed within 6 months, if it becomes stable presently, the patient can be possible to participate).